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ABSTRACT
During the analysis of the La (SS-B) autoantigen for
catalytic activities an ATP-dependent double-stranded
RNA unwinding activity was detected. Both native and
recombinant La proteins from different species
displayed this activity, which could be inhibited by
monospecific anti-La antibodies. La protein was able to
melt dsRNA substrates with either two 3′-overhangs or
a single 3′- and a 5′-overhang. Double-stranded RNAs
with two 5′-overhangs were not unwound, indicating
that at least one 3′-overhang is required for unwinding.
Sequence elements of the La protein that might be
involved in dsRNA unwinding, such as an evolutionarily
conserved putative ATP-binding motif and an element
that is homologous to the double-stranded RNA
binding protein kinase PKR, are discussed.
INTRODUCTION
Sera from patients with autoimmune diseases such as systemic
lupus erythematosus or primary Sjögren’s syndrome frequently
develop autoantibodies to RNA- or DNA-binding proteins (1).
One of the targets of such autoantibodies is the so-called La
(SS-B) protein. The La protein can be found associated with all
primary RNA polymerase III transcripts including precursor
molecules of ribosomal 5S RNA, the tRNAs, some 7S RNAs, as
well as a portion of the U1 and U6 snRNA (2–4). Common to all
primary RNA polymerase III transcripts is the 3′-terminal
oligo(U)-tail, which is transcribed during the transcription
termination step. These oligo(U)-tails were shown to be a binding
site for the La protein (5). In most cases the binding of the La
protein to the primary RNA polymerase III transcripts is only
transient, as their respective oligo(U)-tails are removed after
transcription during an unknown processing step. However, some
small cytoplasmic La RNAs retain their oligo(U)-tails even after
transport to the cytoplasm (6). In addition to the oligo-uridylated
RNA polymerase III transcripts an association of the La protein
with some non-oligouridylated RNAs has been reported
especially for some viral RNAs including the leader RNAs of
vesicular stomatitis virus and rabies virus (6,7).
Recently, the La protein was shown to be involved in internal
initiation of translation of poliovirus mRNA and to alleviate
translational repression by the TAR element in HIV-1 mRNA
(reviewed in ref. 8). As a hypothetical mode of action a dsRNA
unwinding mechanism has been suggested (9). In a previous
report it was described that the La protein is able to melt
DNA–RNA hybrids (10). This activity could explain how the La
protein might release the primary RNA polymerase III transcripts
from their DNA template (10–12). During these experiments an
activation of the La protein-associated ATPase activity was not
only observed for DNA–RNA hybrids but also for
poly(I)·poly(C), an observation which was confirmed by a recent
report of Xiao and co-workers (13) who have shown that La is
able to unwind dsRNA to single-stranded forms. In this report we
extend these observations and show that La is an ATP-dependent
helicase that unwinds dsRNA substrates with either two
3′-overhangs or a single 3′- and 5′-overhang.
MATERIALS AND METHODS
Materials
Isopropyl β-D-thiogalactopyranoside (IPTG), anti-human IgG
(γ-chain specific) conjugated with alkaline phosphatase (A3150;
8 U/ml), anti-mouse IgG developed in sheep [(Fab′)2 fragments]
adsorbed with human serum proteins (A-0532) were obtained
from Sigma (St Louis, MA, USA). The Enhanced Chemilumines-
cence (ECL)-Western blotting detection reagents were from
Amersham-Buchler (Braunschweig, Germany). 4-Nitro-blue-
tetrazolium chloride (NBT) and 5-bromo-4-chloro-3-indolyl
phosphate (BCIP) from Roth (Karlsruhe, Germany). [32P]UTP
(specific radioactivity 3000 Ci/mmol) from Dupont (Dreieich,
Germany). Dinatrium 3-(4-methoxyspiro {1,2-dioxetan-3,2′-
(5′-chloro) tricyclo[3.3.1.1.3,7] decan}-4-yl) phenyl phosphate
(CSPD) was obtained from Tropix (Bedford, MA, USA).
pBluescript II SK(–) and KS(–) were obtained from Stratagene
(Heidelberg, Germany). pGEM-4Z was from Promega (Heidel-
berg, Germany). T7-, SP6- and T3 RNA polymerase, pSPT 19
and various restriction enzymes were obtained from Boehringer
Mannheim, (Mannheim, Germany).
Anti-La antibodies and sera
Monospecific anti-La antibodies were isolated by affinity-
purification from serum W10 (14) using recombinant human La
protein covalently linked to Sepharose 4B. Elution of the bound
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antibodies was performed as described previously (10,15–17).
The anti-La mAb La4B6 was raised against recombinant human
La protein and recognizes the sequence SKGRRFKGKGKGN in
the C-terminal part of the La protein (18).
Preparation of cell extracts
For the preparation of total cell extracts, monolayer human XPTA
cells and mouse 3T3 fibroblasts (ATCC CCL 92) were grown to
confluency in a culture flask. The cells were washed and 500 µl
hot SDS–PAGE sample solution (0.1 M Na2HPO4, pH 8.3; 20%
[w/v] sucrose, 1% SDS, 1 mM PMSF) was added per 200 ml
flask. The lysed cells were heated in an Eppendorf tube for 5 min
at 95C and the resulting protein extract was centrifuged for 15
min at 11 000 g and frozen at –80C until use.
Preparation of the purified La protein fractions
The La protein was biochemically purified as described (16,19)
using heparin- and poly(U)-Sepharose chromatography followed
by immunoaffinity chromatography on anti-La Sepharose. The
native rat La proteins were isolated from either total rat liver
extracts (female Brown Norway) or from extracts obtained by
solubilisation of isolated rat liver nuclei or nuclear envelopes with
Triton X-100 (20). The nuclei and nuclear envelopes were
prepared by the following procedure (all steps at 4C, unless
stated otherwise). Rat liver was minced with a pair of scissors and
homogenized in 4 vol 50 mM Tris–HCl, pH 7.4, 5 mM MgSO4,
250 mM sucrose, 1 mM PMSF. The homogenate was filtrated
through four layers of cheese cloth. After centrifugation at 800 g
for 10 min, the pellet was washed with the same buffer and
resuspended in 50 mM Tris–HCl, pH 7.4, 5 mM MgSO4, 2.1 M
sucrose, 1 mM PMSF. After centrifugation for 60 min at 70 000 g,
the pelleted nuclei were resuspended and applied to a 5 ml sucrose
cushion. Nuclei were obtained by centrifugation for 30 min at
70 000 g. The pelleted nuclei were resuspended in 50 mM
Tris–HCl, pH 7.4, 5 mM MgSO4, 250 mM sucrose, 1 mM PMSF
at a concentration of ∼5 × 108 nuclei/ml. For preparation of
nuclear envelopes the nuclei were incubated with 250 µg/ml
DNase I for 60 min at 30C, after which the nuclei were collected
again by centrifugation (800 g, 10 min). Nuclei were resuspended
in 10 mM Tris–HCl, pH 7.4, 0.2 mM MgSO4, 1 mM PMSF and
subsequently 4 vol 2 M NaCl in 10 mM Tris–HCl, pH 7.4,
0.2 mM MgSO4, 1 mM PMSF were added. 2-Mercaptoethanol
was added to a final concentration of 1% and after an incubation
for 15 min the nuclear envelopes were collected by centrifugation
(1600 g, 30 min). Then the NaCl extraction step was repeated
without the addition of 2-mercaptoethanol. Finally, the nuclear
envelopes were resuspended in 50 mM Tris–HCl, pH 7.4, 5 mM
MgSO4, 5 mM 2-mercaptoethanol, 2.1 M sucrose, 1 mM PMSF
and stored at –70C. Nuclei and nuclear envelopes were extracted
with Triton X-100 as follows. Pelleted nuclei were resuspended
in 25 mM Tris–HCl, pH 7.6, 25 mM KCl, 2.0 mM MgCl2,
0.5 mM CaCl2, 0.3 mM MnCl2, 5.0 mM spermidine–HCl, 250
mM glucose, 5.0 mM 2-mercaptoethanol and Triton X-100 was
added to a concentration of 1%. After an incubation for 10 min
the demembranated nuclei were removed by centrifugation
(1600 g, 10 min). Pelleted nuclear envelopes were resuspended in
50 mM Tris–HCl, pH 7.4, 5 mM MgSO4, 250 mM sucrose, 1 mM
PMSF and were extracted with 2% Triton X-100 for 10 min. The
pore complex laminae were removed by centrifugation (15 000 g,
20 min).
Expression of recombinant La proteins
Two different recombinant human La protein preparations,
termed wt1 and wt2, were used (21,22). Preparation wt1 was
isolated by two ion-exchange chromatographic steps followed by
an immunoaffinity chromatographic step from a bacterial lysate
of Escherichia coli expressing a La cDNA described previously
(23,24). The recombinant human La preparation wt2 and also the
recombinant rat La protein were isolated via a single immuno-
affinity chromatographic step from bacterial extracts, which were
obtained from bacteria expressing either the human (EMBL
accession no. X69804) or rat (EMBL accession no. X67859) La
cDNAs (21). Bound La protein was eluted as described (19). If
not stated otherwise La preparation wt2 was used.
SDS–polyacrylamide gel electrophoresis and
immunoblotting
SDS–PAGE and immunoblotting were performed as described
(25). The blocked membrane was incubated with cell culture
supernatant of hybridoma cells secreting the anti-La mAb La4B6
(18). Immune complexes were detected with anti-mouse per-
oxidase conjugate using the ECL-Western blotting detection
reagents. After elution of the mouse immune complexes (10) the
blot was incubated with monospecific anti-La antibodies isolated
from patient serum W10. The immune complexes were
visualized with anti-human antibodies covalently linked to
alkaline phosphatase using BCIP/NBT as substrate.
Unwinding assay
Plasmid DNAs were obtained from either pSPT 19, pBluescript
II SK(–) and KS(–), or pGEM-4Z. Plasmid DNA was prepared
according to a Qiagen midiprep protocol from Diagen (Hilden,
Germany) and substrate DNAs were made as follows. In the case
of the substrates S1 and S2, pSPT 19 DNA was cut with either
PvuII or NarI, in the case of S3 with either HindIII or NarI, in the
case of S4 with either PvuII or EcoRI and in the case of S5 with
either HindIII or EcoRI. The substrate S6 was prepared from
pBluescript II SK(–) by cutting with either XhoI or NotI. In the
case of the substrate S7 the unlabeled strand was prepared from
pBluescript II KS(–) after cutting with SacI, the labeled strand
was prepared from SK(–) after cutting with KpnI. The substrate
S8 was transcribed from pGEM-4Z cut with PvuII. The resulting
linear DNAs were transcribed in vitro by either SP6-, T7- or T3
RNA polymerase.
In vitro transcription was performed according to the estab-
lished protocols using 1.5 µg of the respective plasmid DNA in
a final volume of 20 µl. In order to label a transcript in vitro
transcription was performed in the presence of 50 µCi
[α-32P]UTP.
Substrates were prepared by annealing two complementary
strands (a 2–3-fold molar excess of the unlabeled strand) in
hybridization buffer [0.4 M NaCl, 1 mM EDTA, 40 mM PIPES,
pH 6.4 and 80%(v/v) formamide] as described (26).
The unwinding of the dsRNA substrate was assayed in a final
volume of 20 µl containing 0.5–1.2 µl substrate and 0.1–5 µg La
protein in a reaction buffer composed of 30 mM Tris–HCl, pH
7.5, 8 mM MgCl2, 1.5 mM DTT, 30 µg/ml BSA, 0.5 U/µl RNasin
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and 2 mM ATP unless stated otherwise. The reaction mixture was
incubated for 15 min at 37C. The reaction was stopped by the
addition of SDS and EDTA to final concentrations of 0.3% and
15 mM respectively.
After unwinding RNAs were separated by SDS–PAGE using
10 or 11.5% gels lacking a stacking gel and the reaction products
were visualized by autoradiography.
RESULTS
During the last few years assay systems have been developed to
test for unwinding activity of putative helicases (26,27). In such
an assay we have analyzed the unwinding of dsRNA substrates
consisting of a hybrid of a radioactively labeled strand and an
unlabeled complementary strand, both transcribed in vitro from
a variety of plasmids (see Materials and Methods). Unwinding of
such a (partially) double-stranded RNA substrate can be detected
because the released labeled strand will usually migrate faster
than the dsRNA in an SDS–polyacrylamide gel.
dsRNA unwinding activity of the La protein
The dsRNA substrate S1 consists of an unlabeled ssRNA
molecule of 357 nucleotides (nt) and a labeled ssRNA of 107 nt,
which, after hybridization, form a substrate with 3′-overhangs of
285 and 35 nt respectively, and a dsRNA region of 72 base pairs
(bp) (A in Fig. 1A). Unwinding of substrate S1 releases the
radiolabeled strand of 107 nt (B in Fig. 1A). S1 was unwound by
recombinant La protein preparations (Fig. 1B, lanes c, d and j) as
well as by the native La protein purified to homogeneity (Fig. 1B,
lane i) when using 0.1 µg La protein/assay. No unwinding activity
was detected in the absence of La protein (Fig. 1B, lane b) nor
with a bacterial protein control (Fig. 1B, lane h). Concentrations
of La protein below 0.1 µg/assay were less effective (lanes e, f and
g), while higher concentrations of La led to more unwinding (see
e.g. Fig. 3A, lane b). The dsRNA unwinding activity was found
for two different recombinant human La protein preparations
termed wt1 (Fig. 1B, lane c) and wt2 (Fig. 1B, lane d) as well as
for a recombinant rat La protein preparation (Fig. 1B, lane j). The
recombinant human La protein preparations were isolated from
total bacterial extracts by different procedures and expressed by
La cDNAs from two different laboratories (see Materials and
Methods). Independent of the isolation procedure equivalent
amounts of recombinant La proteins exhibited similar activities.
The La protein preparations used were essentially free of
contaminating proteins. This became especially evident when the
purified La protein fractions were biotinylated and analyzed by
SDS–PAGE and Western blotting (data not shown). 
Double-stranded RNA unwinding by the La protein required
ATP (Fig. 1C) as only a weak if any activity was found when ATP
was omitted (lane d), or replaced by GTP (lane b) or the
non-hydrolyzable methylene ATP analog (lane c).
With 0.5 µg recombinant human La protein unwinding of
substrate S1 was almost complete after 20 min of incubation at
37C (Fig. 2).
Inhibition of dsRNA unwinding activity of the La
protein by anti-La antibodies
To confirm that the dsRNA unwinding activity was an inherent
activity of the La protein a monospecific polyclonal anti-La
antibody preparation was added to the unwinding assay. As
Figure 1. Unwinding of dsRNA by the La protein. (A) Schematic structure of
substrate S1 (A) and radiolabeled product of unwinding of S1 (B). The numbers
indicate the lengths in nucleotides. A star marks the radiolabeled strand. (B)
Unwinding of substrate S1 by different La protein preparations. Bands A and
B correspond to structures A and B in (A) respectively. Both RNA strands were
transcribed from pSPT 19 DNA. After incubation of substrate S1 in the
presence or absence of La protein preparations, substrate and products were
analysed by SDS–PAGE. The control lanes show the ssRNA, released by
heat-denaturation of substrate S1 (lane a; the amount of denatured substrate
loaded was significantly smaller then the amount used in the other lanes) and
the dsRNA substrate S1 incubated in the absence of any protein preparation
(lane b). In lanes c–j the following protein preparations were used: lane c,
recombinant human La protein (wt1), 0.1 µg; lane d, recombinant human La
protein (wt2), 0.1 µg; lanes e, f and g, recombinant human La protein (wt1),
0.01, 0.02 and 0.05 µg respectively; lane h, control immunoaffinity purified
fraction from bacteria transformed with the expression vector without La cDNA
insert; lane i, purified rat La protein, 0.1 µg; lane j, recombinant rat La protein,
0.1 µg. (C) ATP requirement of unwinding by La. Unwinding activity of 0.5 µg
recombinant human La protein wt2 was assayed after addition of 2 mM ATP
(lane a), 2 mM GTP (lane b), 2 mM non-hydrolyzable ATP analog (lane c), and
in the absence of any NTP (lane d).
Figure 2. Time-course of dsRNA unwinding by the La protein. Substrate S1
was incubated with 0.5 µg recombinant human La protein wt2 for 0 min (lane b;
reaction stopped immediately after addition of the La protein), 10 min (lane c)
or 20 min (lane d). Lane a contains the dsRNA substrate and in lane e the
dsRNA substrate was heat denatured before gel electrophoresis.
shown in Figure 3A the affinity-purified anti-La antibody
preparation (W10) inhibits the unwinding activity of the recombi-
nant human La protein (1 µg/assay) in a dose-dependent manner
(lanes b, c and d). The specificity of the anti-La antibodies used
is illustrated by the Western blot in Figure 3B, which was
prepared using total extracts obtained from either human or
mouse cultured cells. The specificity of W10 antibodies (Fig. 3B,
413
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Figure 3. Inhibition of dsRNA unwinding activity by anti-La antibodies. (A)
Anti-La antibodies inhibit the unwinding of substrate S1 by La. The unwinding
of substrate S1 by 1 µg recombinant human La protein wt2 was analyzed in the
presence of increasing amounts (lane b, 0.1 µg; lane c, 1 µg; lane d, 5 µg) of
purified, monospecific human anti-La antibodies from patient serum W10.
Lane a shows the products from a control incubation in the absence of La
protein. (B) Specificity of anti-La antibodies. Total extracts from cultured
human (lanes a and c) and mouse (lanes b and d) cells were fractionated by
SDS–PAGE and transfered to membranes by Western blotting to analyze the
specificity of the affinity-purified human W10 anti-La antibodies (lanes c
and d) and anti-La monoclonal antibody La4B6 (lanes a and b) as a control. The
position of molecular weight markers is indicated on the right (MW; in kDa).
lanes c and d) was indistinguishable from that of the monoclonal
anti-La antibody La4B6 (Fig. 3B, lanes a and b). Both stain a
single protein band with a molecular weight of ∼50 kDa in the
human cell extract and of ∼47 kDa in the mouse cell extract, in
accordance with the apparent molecular weight of the La protein
from these species.
Copurification of the unwinding activity with La from
rat liver extract
The results described above indicated that also the rat La protein
displayed dsRNA unwinding activity. To substantiate these data
and to investigate whether the unwinding activity indeed
represented an endogenous activity of the rat La protein, the
protein was extensively purified from rat liver. Rat liver extract
was fractionated by ammonium sulphate precipitation, Sephadex
G-150 gel filtration, depletion by anti-Ro antibodies (to remove
Ro RNPs which are known to be stably associated with a subset
of La molecules) and finally heparin chromatography. The La
containing fractions of the heparin column were further fraction-
ated by poly(U)–Sepharose chromatography followed by anti-La
immunoaffinity chromatography. The presence of the La protein
in all fractions was assayed by Western blotting using monoclonal
and patient anti-La antibodies. When La containing fractions
from the last three columns were analysed in the dsRNA
unwinding assay, all were able to unwind dsRNA (Fig. 4, lanes
b–g). Also La protein isolated by immunoaffinity chromatogra-
phy from lysed rat liver nuclei or nuclear envelopes was able to
unwind substrate S1 (Fig. 4, lanes h–k).
From the combined results described above it was concluded
that the unwinding activity is an endogenous activity of the La
protein.
Substrate specificity of dsRNA unwinding by La
As depicted before substrate S1 was composed of a double-
stranded region of 72 bp bordered by two 3′-overhangs. When the
357 nt strand was radiolabeled (substrate S2) instead of the
Figure 4. Copurification of the dsRNA unwinding activity with La. The La
protein was purified from rat liver by the procedure described in the Materials
and Methods section. Various fractions of (partially) purified La were assayed
for unwinding of substrate S1. Lane a shows the dsRNA substrate incubated in
the absence of any La protein. In lanes c, e, g, i and k, a 3-fold amount of the
same La fraction was used as in lanes b, d, f, h and j respectively. Substrate S1
was incubated with the following: lanes b and c, La isolated from a rat liver
extract by ammonium sulphate precipitation, Sephadex G-150 gel filtration,
anti-Ro depletion and heparin chromatography; lanes d and e, La isolated from
a rat liver extract as described for lanes b and c but further purified by
poly(U)–Sepharose chromatography; lanes f and g: La isolated from a rat liver
extract as described for lanes d and e but further purified by anti-La
immunoaffinity chromatography; lanes h and i, La isolated by immunoaffinity
chromatography from a rat liver nuclei preparation obtained by solubilization
of isolated nuclei with Triton X-100; lanes j and k, La isolated by
immunoaffinity chromatography from a rat liver nuclear envelope preparation
obtained by solubilization of isolated nuclear envelopes with Triton X-100. In
lane l recombinant human La preparation wt2 was used as a control.
shorter 107 nt strand as in S1, unwinding could not be assessed
due to the fact that the relatively long radiolabeled strand
comigrated with the substrate in the gel (results not shown).
To learn more about the substrate specificity of unwinding by
the La protein, a number of other substrates were prepared.
Substrate S3 consisted of a hybrid between an unlabeled ssRNA
of 357 nt and a labeled ssRNA of 61 nt, which was completely
complementary to a region of the longer strand. This resulted in
a substrate containing a double-stranded region of 61 bp and both
a 3′- and a 5′-overhang (Fig. 5A, band A). The La protein was able
to release the small labeled ssRNA from this substrate (Fig. 5A,
lane b, band B).
Substrate S4 was identical to substrate S3 except for the fact
that the other strand (357 nt) was radiolabeled. As observed for
S2, substrate S4 and its unwinding product displayed similar
mobilities (results not shown), implying that unwinding of S4
could not be assessed.
Next three different substrates were prepared with 5′-over-
hangs at both ends. Substrate S5 consisted of an unlabeled ssRNA
of 62 nt and a labeled ssRNA of 61 nt, which after hybridization
resulted in a double-stranded region of 51 bp and two 5′-over-
hangs of 11 and 10 nt (Fig. 5B, band A). Substrate S6 consisted
of an unlabeled ssRNA of 101 nt and a labeled ssRNA of 104 nt,
which after hybridization resulted in a double-stranded region of
72 bp and two 5′-overhangs of 29 and 32 nt (Fig. 5C, band A).
Substrate S7 consisted of an unlabeled ssRNA of 117 nt and a
labeled ssRNA of also 117 nt, which after hybridization resulted
in a double-stranded region of 102 bp and two 5′-overhangs of 15
nt (Fig. 5D, band A). Neither S5, nor S6, nor S7 were unwound
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Figure 5. Substrate specificity of dsRNA unwinding by La. Various substrates
were incubated with 2 µg (unless stated otherwise) of purified La preparation
wt2 and analyzed as described in Materials and Methods. (A) Substrate S3
(band A) consisted of an unlabeled 357 nt ssRNA and a labeled 61 nt ssRNA
resulting in a substrate with both 3′- and 5′-overhangs. The position of the
labeled product of the unwinding reaction (band B) is indicated. Lanes a and b
contain material from incubations in the absence and presence of La protein,
respectively. (B) Substrate S5 (band A) consisted of an unlabeled 62 nt ssRNA
and a labeled 61 nt ssRNA resulting in a substrate with two 5′-overhangs. The
position of the radiolabeled ssRNA was determined by heat denaturation of
substrate S5 (lane a) and is indicated by B. Lanes b and c contain material from
incubations in the absence and presence of La protein, respectively. (C)
Substrate S6 (band A) consisted of an unlabeled 101 nt ssRNA and a labeled
104 nt ssRNA resulting in a substrate with two 5′-overhangs. The position of
the radiolabeled ssRNA was determined by heat denaturation of substrate S6
(lane a) and is indicated by B. Lanes b and c contain material from incubations
in the absence and presence of La protein, respectively. (D) Substrate S7 (band
A) consisted of an unlabeled 117 nt ssRNA and a labeled 117 nt ssRNA
resulting in a substrate with two 5′-overhangs. The position of the radiolabeled
ssRNA was determined by heat denaturation of substrate S7 (lane a) and is
indicated by B. Lanes b and c contain material from incubations in the absence
and presence of La protein, respectively. (E) Substrate S8 (band A) was created
from a labeled 181 nt ssRNA and an unlabeled 271 nt ssRNA and contained two
3′-overhangs of 111 and 201 nt respectively. The position of the radiolabeled
ssRNA was determined by heat denaturation of substrate S8 (lane a) and is
indicated by B. Lanes b and c contain material from incubations in the absence
and presence of (0.5 µg) La protein, respectively.
by the recombinant La protein (Fig. 5B–D) strongly suggesting
that at least one 3′-overhang was required for unwinding by La.
To exclude the possibility that the unwinding of S1 and S3 by
La was dependent on a particular sequence element that might be
shared by these substrates in view of the fact that they were
derived from the same plasmid, substrate S8 was prepared using
a different plasmid. This substrate consisted of an unlabeled
strand of 271 nt and a labeled strand of 181 nt, which after
hybridization resulted in a double-stranded region of 70 bp and
two 3′-overhangs of 201 and 111 nt, respectively. Since S8 was
unwound by the La protein (Fig. 5E, lane c) we conclude that the
presence of a 3′-overhang rather than a particular sequence
element is required for dsRNA unwinding by La.
DISCUSSION
In this report we describe an intrinsic enzymatic property of the
La protein, namely an ATP-dependent dsRNA unwinding
activity. We further present evidence that only dsRNA substrates
with a 3′-overhang are unwound.
It is obvious that these results are only of interest when it can
be shown convincingly that this unwinding activity is displayed
by the La protein and not due to some minor contamination of the
La preparation used. The following arguments support the notion
that dsRNA unwinding is indeed exerted by the La protein.
(i) The unwinding activity was displayed by recombinant
(human, rat) and native (rat liver) La protein purified from
different organisms (E.coli, rat). Various purification protocols
including ammonium sulphate precipitation followed by gel
filtration, heparin chromatography and various affinity chroma-
tography steps were unable to separate or remove the unwinding
activity from the La protein. Although SDS–PAGE analyses of
the various preparations (not shown) revealed almost identical
protein profiles [full length La protein and its well-known
degradation products (6,7,18)] such protein staining patterns can
of course not exclude the possibility that some minor contamina-
tion of E.coli or rat liver proteins is present.
(ii) Affinity-purified patient anti-La antibodies are able to
inhibit the unwinding activity. This result further corroborates our
conclusion that the unwinding activity is an intrinsic property of
the La protein, because it is very unlikely that the antibodies
would also bind to a possible contamination.
(iii) Some mutant La proteins are unable to unwind the dsRNA
substrate (unpublished observations). These mutants were puri-
fied from E.coli in the same way as the active wt La proteins, and
as a consequence would be expected to contain the same set of
contaminating proteins.
(iv) Purified and active La preparations are able to unwind
dsRNAs with a 3′-overhang to completion but are unable to
unwind similar substrates with merely 5′-overhangs.
Taken together we feel confident to conclude that the La protein
is not only able to melt DNA–RNA hybrids, as has been reported
before (10), but is also an ATP-dependent dsRNA unwinding
enzyme. While this work was in progress dsRNA unwinding by La
has also been reported in relation with the ability of La to inhibit
activation of the dsRNA dependent protein kinase PKR (13).
Presently, the mechanism by which La unwinds dsRNA is
unknown. The observation that a 3′-overhang is required might
suggest that unwinding is initiated at the border of double-
stranded and single-stranded RNA in the substrate. In the in vitro
unwinding assay the concentration of recombinant La was in the
micromolar range and the concentration of substrate RNA in the
nanomolar range implying that the single-stranded RNA binding
activity of La may act to change the equilibrium between dsRNA
and its single-stranded components. Although we cannot exclude
yet that La acts in a stoichiometric rather than a catalytic fashion,
preliminary unwinding data obtained with mutants of La suggest
that in addition to the RNA binding domain at the N-terminus of
La also elements in the C-terminal part are required for
unwinding (unpublished observations). In addition, it is not
known which percentage of the recombinant La protein mol-
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ecules is biologically active and thus the effective concentration
of recombinant La in the unwinding assay might be much lower
than the total concentration of La protein. Based upon these
considerations and the fact that ATP is required for unwinding, we
favour a mechanism in which La acts in a catalytic fashion, but
additional experiments are required to confirm this.
The helicase domain of La
During the last few years a rapidly growing protein family of
putative RNA helicases with the common amino acid motif
DEAD or DEXH have been described (29). Sequence compari-
sons of these putative unwinding enzymes resulted in the
identification of up to eight common elements (27,29) including
the so-called A or Walker motif, representing the ATP binding
site, and the B-motif also known as DEAD/DEXH box. For only
a few of the DEAD box proteins, e.g. eIF-4A and the protein p68
(30,31), an ATP-dependent helicase activity has been demon-
strated. In some other cases, for example the SrmB protein and the
prp16 protein, only an RNA-dependent ATPase activity was
established (32,33). An RNA-dependent ATPase activity asso-
ciated with the capability to melt DNA–RNA hybrids has been
described for the procaryotic transcription termination factor rho
(34) and for the autoantigen La (SS-B) (10). For the latter protein
also a dsRNA unwinding activity was proposed and has now been
firmly established (13, this paper).
The question arises whether the La protein contains amino acid
sequences related to the A- and the B-motifs or to other conserved
regions of DEAD/DEXH box proteins. Recently Topfer and
co-workers (28) pointed out that the La protein contains the
evolutionarily conserved (36) sequence motif A/GXXXXGKG
(amino acids 333 to 340 in human La). This sequence represents
the major part of the A-motif with only one difference, the final
amino acid T of the A motif A/GXXXXGKT is replaced by a G.
A similar deviation has been found in the ATP-binding site of some
other ATP-binding proteins as for example adenylate kinase and
the H(+)-ATPase of E.coli (35). Most recently, a monoclonal
anti-La antibody (La4B6) directed to this putative ATP-binding site
was generated. It could subsequently be shown that ATP abolished
the binding of La4B6 to the La protein (18), indicating that this site
indeed interacts with ATP. Although the La protein does not belong
to the DEAD or DEXH families of RNA helicases, a sequence
sharing some similarity to the B-motif can be discerned in the
human La protein: DDEHDEHDENG, starting at position 367.
Further experiments are required to investigate whether this
element is required for the unwinding activity.
Finally, Clemens (37) indicated that the La protein shares some
sequence homologies with the interferon induced dsRNA de-
pendent protein kinase PKR (also known as DAI), primarily in
regions reminiscent of a dsRNA binding motif (38). Interestingly,
most of the amino acids suggested to be conserved in these PKR
related motifs appear to be conserved in La from different species.
Moreover, the B-motif related cluster of acidic amino acids flanks
the PKR dsRNA binding motif-like element at the C-terminal
side. Experiments are in progress to investigate whether (some of)
these elements are involved in the unwinding activity.
Possible function of the dsRNA unwinding activity
Members of the DEAD/DEXH protein families are known, or
suggested, to be involved in diverse cellular functions including
translation initiation, splicing, ribosome assembly, cell growth
and division, embryogenesis and spermatogenesis (39). Also the
La protein can be expected to be involved in a number of cellular
processes. Its function in the nucleus as an RNA polymerase III
transcription termination factor has been firmly established
(11,12,40), but cytoplasmic functions of La cannot be ruled out.
It has been suggested previously that La might shuttle between
nucleus and cytoplasm in dependence on transcription (15,16) or
infection with various viruses such as herpes-, adeno- and
poliovirus (9,41). Indeed, Peek and co-workers provided further
evidence for a partially cytoplasmic localization of the La protein
using cell-enucleation as fractionation method (14), which is
substantiated by the recent demonstration that a subset of La
molecules is associated with small ribosomal subunits (23). In
line with these findings, it has been suggested that the La protein
could be involved in the internal initiation of poliovirus mRNA
translation (9,42). In this respect an interesting observation of the
present study is that a 3′-overhang in the RNA is required for
unwinding. Secondary structures in 5′-UTRs of mRNAs and in
internal ribosomal entry sites will always be accompanied by
‘3′-overhangs’ and therefore it is tempting to speculate that the
dsRNA unwinding activity of the La protein melts such
secondary structures thereby stimulating initiation of translation.
Internal initiation may not only occur on viral RNAs but could
also be used by other cellular mRNAs, such as protooncogene
mRNAs and mRNAs of growth factors or in translation of
proteins involved in the regulation of mitotic events (9). It is
conceivable that the dsRNA unwinding activity of La is involved
in the internal initiation process.
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